Odd Lots

Bloomberg’s Joe Weisenthal and Tracy Alloway take you on a not-so random weekly walk through hot topics in markets, finance and economics.

https://bloomberg.com/podcasts/odd_lots

Eine durchschnittliche Folge dieses Podcasts dauert 33m. Bisher sind 310 Folge(n) erschienen. Dieser Podcast erscheint wöchentlich
subscribe
share





Two Investors Did A Tour Of The Globe To Find The Best Place To Put Their Money


As many active fund managers have discovered in recent years, it’s extremely hard to find a sustainable edge in investing. But for people who put in hard work to discover opportunities off the beaten track, it may still be possible to find undiscovered value. On this episode, we speak with Burton Flynn and Ivan Nechunaev of Terra Nova Capital Advisors about their highly unusual approach to doing research...


share







 2020-06-08  55m
 
 

This Is What Happened To LIBOR During The COVID Crisis


Part V of the Odd Lots LIBOR Series


share







 2020-06-05  54m
 
 

How The Transition Away From LIBOR Is Actually Going


Part IV of the Odd Lots LIBOR series


share







 2020-06-04  34m
 
 

The Case for AMERIBOR As The Replacement for LIBOR


Part III of the Odd Lots LIBOR series


share







 2020-06-03  35m
 
 

This Is The Index That's Supposed To Replace LIBOR


Part II of the Odd Lots LIBOR series


share







 2020-06-02  33m
 
 

Meet the Man Who Blew the Whistle on LIBOR


Part I of the Odd Lots LIBOR series


share







 2020-06-01  43m
 
 

episode 45: A New Vaccine Frontrunner


As competitors publicly entered the race to produce a vaccine, drug giant Merck stayed quiet about its development plans. Now, the company has revealed it’s working on two vaccines and a treatment pill -- emerging as a frontrunner in the development contest. Although the company has refused to give firm timelines for its research, it has pledged to make its vaccines and pill available globally, if they're successful. Riley Griffin talked with Merck Chief Executive Kenneth C...


share







 2020-05-28  14m
 
 

Here’s Who Really Benefits From The Dominance Of The U.S. Dollar


When people talk about the dominance of the U.S. dollar in global commerce, they often refer to it as a unique privilege of the United States that its currency is the world’s safe haven. But it’s not so clear who really benefits from the unique role played by the greenback. For one thing, there are wide swathes of U.S. workers whose industries are hurt by its strength...


share







 2020-05-28  42m
 
 

Three Sovereign Debt Experts Explain How The World Can Instantly Bring Aid To Emerging Markets


The economic crisis will result in an extraordinary amount of pain for emerging markets. In addition to the health disruption, the global economic collapse means that in many cases, exports have come to a standstill. So how can poorer countries be helped right now? On this episode, we speak with three experts in the field of sovereign debt. Lee Buchheit is formerly at Cleary Gottlieb and is considered to be the world’s foremost expert on sovereign debt law and restructurings...


share







 2020-05-25  46m
 
 

What The Weak Recovery In Japan Can Teach Us About Re-Igniting The U.S. Economy


Even with the recent stock market rally, expectations are poor for a robust recovery in the U.S. So what does history teach us about what works and what doesn’t? Richard Werner is an economist at Linacre College at the University of Oxford, and the proponent of what he calls the “Quantity Theory of Credit.” On this episode, he tells us about what he learned studying years of the Japanese economy, and what it means for the current crisis.


share







 2020-05-21  52m